NIH RFA · NHLBI · R03
RFA-HL-27-004: Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards
This is a Notice of Funding Opportunity (NOFO) for a Limited Competition that invites applications from eligible organizations to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the applications will be peer-reviewed, and only meritorious applications will be considered. The purpose of this NOFO is to solicit current or recently completed NHLBI K01, K08, K23, and K25 awardees for small grant support to expand their current research objectives or to branch out to a new study emerging from their K award research. This NOFO is intended to facilitate the transition to research independence for these NHLBI K awardees.…
- NOFO number
- RFA-HL-27-004
- Type
- RFA
- Activity code
- R03
- Primary institute
- NHLBI · National Heart, Lung, and Blood Institute
- Clinical trials
- Optional
- Posted
- May 12, 2026
- Opens
- Jun 9, 2026
- Expires
- Nov 8, 2028
RFA-HL-27-004 due dates
6 application due dates remain before the NOFO expires. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.
| New | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
|---|---|---|---|---|---|
| July 09, 2026 | July 09, 2026 | Not Applicable | November 2026 | January 2027 | April 2027 |
| October 06, 2026 | November 06, 2026 | Not Applicable | March 2027 | May 2027 | July 2027 |
| February 10, 2027 | March 10, 2027 | Not Applicable | July 2027 | October 2027 | December 2027 |
| June 09, 2027 | July 09, 2027 | Not Applicable | November 2027 | January 2028 | April 2028 |
| October 08, 2027 | November 08, 2027 | Not Applicable | March 2028 | May 2028 | July 2028 |
| February 10, 2028 | March 10, 2028 | Not Applicable | July 2028 | October 2028 | December 2028 |
| June 07, 2028 | July 07, 2028 | Not Applicable | November 2028 | January 2029 | April 2029 |
| October 06, 2028 | November 07, 2028 | Not Applicable | March 2029 | May 2029 | July 2029 |
What its predecessor RFA-HL-25-011 funded
RFA-HL-27-004 reissues RFA-HL-25-011. Until awards appear under the new number, its funding history is the best guide to who wins under this program: 44 projects and $9.6M in FY2022–FY2026.
Projects funded
44
Distinct projects, FY2022–FY2026
New awards
44
Type 1 (new project) award records
NIH funding
$9.6M
Award dollars under RFA-HL-25-011, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 0 | 0 | $0 |
| FY2024 | 0 | 0 | $0 |
| FY2025 | 0 | 0 | $0 |
| FY2026 | 44 | 44 | $9.6M |
Institutions with the most funding
- University of Alabama at Birmingham$684K · 3 projects
- Brigham and Women's Hospital$658K · 3 projects
- Yale University$504K · 2 projects
- University of Washington$498K · 2 projects
- UT Southwestern Medical Center$495K · 2 projects
- Columbia University Health Sciences$494K · 2 projects
- Johns Hopkins University$427K · 2 projects
- University of Tennessee Health Sci Ctr$253K · 1 project
Funding institutes
- NHLBI$9.6M · 44
Activity codes funded
- R0344 records
Most recent new awards
- Dissecting von Willebrand factor secretory machinery for therapeutic vulnerabilities (opens NIH RePORTER)
Yale University · 1R03HL185097-01 · NHLBI · Notice Sep 17, 2026
$252KR03
- Integration of omics data to understand dietary fiber's effects (opens NIH RePORTER)
University of Missouri-Columbia · 1R03HL187212-01 · NHLBI · Notice Sep 4, 2026
$232KR03
- Mindful Movement: Development of A Novel Guided Imagery App to Promote Physical Activity in Adults with Overweight or Obesity (opens NIH RePORTER)
University of Tennessee Knoxville · 1R03HL187201-01 · NHLBI · Notice Sep 1, 2026
$217KR03
- Examining the impact of state recess legislation on recess provision in California to inform improved student cardiometabolic fitness (opens NIH RePORTER)
Univ of Calif/Div/Agriculture/Nat/Resour · 1R03HL185215-01 · NHLBI · Notice Sep 1, 2026
$189KR03
- In Vivo Assessment of Placental Vascular Health in Gestational Diabetes Mellitus (opens NIH RePORTER)
Children's Hospital of Los Angeles · 1R03HL187226-01 · NHLBI · Notice Aug 27, 2026
$225KR03
- Evaluation of digital angiogenesis in scleroderma by molecular imaging (opens NIH RePORTER)
Yale University · 1R03HL187219-01 · NHLBI · Notice Aug 26, 2026
$252KR03
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
Participating institutes
2 NIH institutes and offices take applications under RFA-HL-27-004. Contact the program officer at the institute that fits your research before applying.
- NHLBI · National Heart, Lung, and Blood Institute
- none
Related notices
NIH lists no related notices for RFA-HL-27-004 yet.
Award terms
- Application types allowed
- New Resubmission The OER Glossary and the How to Apply Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.
- Award budget
- Application budgets are limited to direct costs up to 85,000 per year, but must reflect actual needs of the proposed project.
- Project period
- The scope of the proposed project should determine the project period. The maximum project period is two years. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.
- Funds available and number of awards
- The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.NHLBI intends to commit total costs up to 3.9 million in FY2027, 7.8 million in FY2028, 7.8 million in FY2029, and 3.9 million in FY2030 for this program.NHLBI intends to fund up to 29 new awards per year in FY2027, FY2028, and FY2029.
Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.
Related NOFOs
- Reissue of RFA-HL-25-011.
Other open NOFOs for R03
- PAS-27-028Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional)NIDA · next due Oct 16, 2026
- PAR-27-074Limited Competition: Small Grant Program for Mentored Research Career Development Award Recipients (R03) (Clinical Trials Not Allowed)NIAMS · next due Oct 16, 2026
- PAR-25-370Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)NHGRI · next due Oct 16, 2026
- PAR-25-091Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)NIDDK · next due Oct 16, 2026
- PA-25-302NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)NIH · next due Oct 16, 2026
- PA-25-125NICHD Small Research Grant Program (R03 Clinical Trial Required)NICHD · next due Oct 16, 2026
About this page
GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.